Tesla: Consensus Earnings Expectations For Q2

Tesla (NASDAQ: TSLA) will be reporting their second quarter financial results on July 26th after market close. Analysts have a consensus $686.94 12-month price target on the company, via a total of 38 analysts, with eight analysts having strong buy ratings. Six analysts meanwhile have buy ratings, 15 have hold ratings, five analysts have a sell rating and four have strong sells on the company. The street high comes from Elazar Advisors with a $1,471 price target, and the lowest target sits at $67 from GLJ Research.

22 analysts have revenue estimates for the second quarter. The mean revenue estimate between all 22 analysts is $11.299 billion; this number has been flat since the start of the year. The highest revenue estimate is $12.827 billion, while the lowest is $9.5 billion.

Onto EBITDA estimates, there are currently 11 analysts who have second-quarter EBITDA estimates. The mean is currently $2 billion, with this number having been flat since the start of the year. The street high estimate currently sits at $2.5 billion in EBITDA and the lowest is $1.5 billion.

Analysts estimate that quarterly earnings per share will come in at $0.98, with this number being flat since the start of the year. Street high is $1.34 and the lowest estimate is $0.62 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Gold Could Fall Further. Here’s What I’m Buying | Rick Rule

Newmont Crushed Q3. So Why Did the Stock Fall?

Governments Bet on Critical Minerals While Investors Panic | John Passalacqua – First Phosphate

Recommended

First Majestic Hits 4.24 g/t Gold Over 48.8 Metres at Saval as Jerritt Canyon Restart Advances

First Majestic Lifts Q3 Revenue 38% to US$394.1 Million on Higher Silver Prices

Related News

Organigram: Consensus Analyst Estimates For Q2 2021

Organigram Holdings (TSX: OGI) (NASDAQ: OGI) will be reporting their fiscal second quarter on April...

Saturday, April 10, 2021, 01:35:00 PM

Dollarama: Analysts Anticipate $972.5 Million In Q1 2022 Revenue

Dollarama Inc (TSX: DOL) will be reporting its first quarter 2022 financial results on June...

Tuesday, June 8, 2021, 05:06:00 PM

Hexo: Analysts Anticipate $34.4 Million In Q3 Revenues

Hexo Corp (TSX: HEXO) (NYSE: HEXO) announced that they will be reporting their fiscal third quarter...

Saturday, June 12, 2021, 01:11:00 PM

Canaccord: 2020 To Be Transition Year For Medipharm Labs

Last week, Medipharm Labs (TSX: LABS) reported their second-quarter earnings. Revenue came in at $13.9...

Saturday, August 22, 2020, 01:38:00 PM

CloudMD: Canaccord Lowers Target After Leading $55 Million Bought Deal

On March 9th, CloudMD Software & Services (TSXV: DOC)  announced that their C$55 million bought...

Tuesday, March 16, 2021, 04:08:00 PM